The present invention provides compositions of binding molecules
specifically binding to a coronavirus such as SARS-CoV and capable of
neutralizing an infection caused by the virus. The compositions are
suitable for diagnosing, preventing and/or treating a condition resulting
from a coronavirus such as SARS-CoV.
